Apellis Pharmaceuticals

Yahoo Finance • 5 hours ago

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Wall Street’s major market averages ended mixed on Thursday as markets assessed President Donald Trump’s address to the nation and the latest developments in the Middle East conflict. The tech-focused Nasdaq Composite finished +0.1%. At t... Full story

Yahoo Finance • 2 days ago

Where the New Houses Are—and What That Says About Growth

Recent statistics show that areas with the greatest population growth tend to be in the Sunbelt where new, affordable construction is taking place. Continue Reading... Full story

Yahoo Finance • 2 days ago

Catalyst Watch: OPEC meeting, FedEx talks freight, inflation reads, and SpaceX IPO buzz

[Wall street and Broadway road sign in New York City] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. SUN... Full story

Yahoo Finance • 4 days ago

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More

Quick Read Stocks were higher across all major indices, as hopes for a speedy end to the Iran war remain in place. Short covering and end-of-quarter “window dressing” were cited as two reasons that aided the massive rally. With first-quar... Full story

Yahoo Finance • 4 days ago

Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout

Biogen has forged a $5.6bn deal to acquire immunology and rare disease specialist Apellis Pharmaceuticals – marking another M&A milestone in a flurry of pharma deal activity at the end of Q1. As per the agreement, Biogen will pay $41 per... Full story

Yahoo Finance • 5 days ago

Wall Street Marks Best Day Since May, Finishes March With Steep Losses

US equity benchmarks logged their biggest one-day gains since May, though Wall Street finished March PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Stock market today: Dow soars 1,000 points, S&P 500 and Nasdaq surge in upbeat end to brutal quarter

US stocks surged on Tuesday after the Iranian president, Masoud Pezeshkian, signaled that the regime may be willing to negotiate toward an end to the war that has ravaged the global energy market. Stocks were already in the green earlier... Full story

Yahoo Finance • 5 days ago

Stocks Climb on Hopes for an End to Iran War

The S&P 500 Index ($SPX) (SPY) today is up +1.02%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.67%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.10%.  June E-mini S&P futures (ESM26) are up +1.10%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 5 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 2% and the St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Stock market today: Dow surges 1,000 points, S&P 500 and Nasdaq soar after Iranian leader signals openness to negotiations

US stocks surged in afternoon trading on Tuesday after the Iranian president, Masoud Pezeshkian, signaled that the regime may be willing to negotiate toward an end to the war that has ravaged the global energy market. Stocks were already... Full story

Yahoo Finance • 5 days ago

Sector Update: Health Care Stocks Higher Tuesday Afternoon

Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 1.5% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Correction: Sector Update: Health Care Stocks Advance Premarket Tuesday

(Corrects the upfront cash consideration in the second paragraph to $6.3 billion.) Health care st PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • 5 days ago

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio Proactive uses images sourced from Shutterstock Biogen Inc (NASDAQ:BIIB, XETRA:IDP) will acquire Apellis Pharmaceuticals Inc (NASDAQ:APLS) for $41 per s... Full story

Yahoo Finance • 5 days ago

Biogen Eyes Immunology, Rare Disease Portfolio Boost With Apellis Pharmaceuticals Acquisition

Biogen (BIIB) agreed to acquire biopharmaceutical firm Apellis Pharmaceuticals (APLS), strengthening PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Top Midday Stories: McCormick to Combine With Unilever's Foods Business; Eli Lilly to Acquire Centessa for Up to $7.8 Billion

All three major US stock indexes were up, while the price of oil was down in late-morning trading Tu PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Nvidia invests $2B in Marvell, Eli Lilly to buy drugmaker Centessa

Yahoo Finance Senior Reporter Brooke DiPalma takes a closer look at some of Tuesday morning's trending tickers and stories, including some of the latest deals and investments. Nvidia (NVDA) is investing $2 billion in Marvell (MRVL). Biog... Full story

Yahoo Finance • 5 days ago

Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 – Here’s Why

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is one of the best high growth healthcare stocks to buy now. Cantor Fitzgerald cut the price target on Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) to $31 from $35 on March 13, reiterating an Over... Full story

Yahoo Finance • 5 days ago

Sector Update: Health Care Stocks Advance Premarket Tuesday

Health care stocks were advancing premarket Tuesday, with the State Street Health Care Select Sector PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Biogen To Acquire Apellis, Expanding Its Immunology And Rare Disease Portfolio; Stock Up

(RTTNews) - Biogen Inc. (BIIB) has agreed to acquire Apellis Pharmaceuticals (APLS) in a deal that strengthens its position in immunology, rare disease and nephrology. The acquisition brings two commercial medicines-EMPAVELI and SYFOVRE-... Full story

Yahoo Finance • 5 days ago

Biogen Snaps Up Apellis Pharma For $5.6 Billion, But Biogen Dives As Apellis Soars

Biogen struck a deal Tuesday to buy Apellis Pharmaceuticals for $5.6 billion. The buyout adds two approved drugs to Biogen's pipeline. Continue Reading... Full story